Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophrenia

International Psychogeriatrics

Volumn 27, Issue 1, 2015, Pages 131-134

  Pridan, Shani ^a   Swartz, Marnina ^a   Baruch, Yehuda ^a   Tadger, Shelly ^a   Plopski, Igor ^a   Barak, Yoram ^a  

^a ABARBANEL MENTAL HEALTH CENTER   (Israel)

Author keywords

antipsychotics; psychopharmacology; schizophrenia

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; DISEASE DURATION; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; DRUG TREATMENT FAILURE; DSM-IV-TR; FEMALE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; RETROSPECTIVE STUDY; SCHIZOPHRENIA; TREATMENT OUTCOME; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG RESISTANCE; ISRAEL; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; STATISTICS AND NUMERICAL DATA;

AGED; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG RESISTANCE; FEMALE; HUMANS; INPATIENTS; ISRAEL; MALE; MIDDLE AGED; MORTALITY; PATIENT READMISSION; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 84927595769     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610214001756     Document Type: Article

References (20)

1. Aparasu, R. R., Jano, E., Johnson, M. L. and Chen, H. (2008). Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elDerly patients. American Journal of Geriatric Pharmacotherapy, 6, 198-204
2. Barak, Y., Wittenberg, N., Naor, S., Kutzuk, D. and Weizman, A. (1999). Clozapine in elDerly psychiatric patients: tolerability, safety, and efficacy. Comprehensive Psychiatry, 40, 320-325
3. Chahine, L. M., Acar, D. and Chemali, Z. (2010). The elDerly safety imperative and antipsychotic usage. Harvard Review of Psychiatry, 18, 158-172
4. Czobor, P., Volavka, J. and Meibach, R. C. (1995). Effect of risperidone on hostility in schizophrenia. Journal of Clinical Psychopharmacology, 15, 243-249
5. Davidson, M. et al. (2000). A long-term, multicenter, open-label study of risperidone in elDerly patients with psychosis. On behalf of the Risperidone Working Group. International Journal of Geriatric Psychiatry, 15, 506-514
6. De Hert, M., Correll, C. U. and Cohen, D. (2010). Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. Schizophrenia Research, 117, 68-74
7. Frankenburg, F.R. and Kalunian, D. (1994). Clozapine in the elDerly. Journal of Geriatric Psychiatry and Neurology, 7, 129-132
8. Gareri, P., De Fazio, P., Russo, E., Marigliano, N., De Fazio, S. and De Sarro, G. (2008). The safety of clozapine in the elDerly. Expert Opinion Drug Safety, 7, 525-538
9. Guenette, M. D. et al. (2013). Risk of neutropenia in a clozapine-treated elDerly population. Schizophrenia Research, 148, 183-185
10. Herst, L. and Powell, G. (1997). Is clozapine safe in the elDerly? Australian and New Zealand Journal of Psychiatry, 31, 411-417
11. Howanitz, E. et al. (1999). The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. Journal of Clinical Psychiatry, 60, 41-44
12. Jskelinen, E. et al. (2013). A systematic review and meta-Analysis of recovery in schizophrenia. Schizophrenia Bullettin, 39, 1296-1306
13. Leucht, S. et al. (2013). Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-Analysis. Lancet, 382, 951-962
14. Marriott, R. G., Neil, W. and Waddingham, S. (2006). Antipsychotic medication for elDerly people with schizophrenia. Cochrane Database Systemic Reviews, 1, CD005580
15. McEvoy, J. P. et al. (2006). Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. American Journal of Psychiatry, 163, 600-610
16. Meltzer, H. Y. (2012). Clozapine: balancing safety with superior antipsychotic efficacy. Clinical Schizophrenia and Related Psychoses, 6, 134-144
17. Sajatovic, M., Jaskiw, G., Konicki, P. E., Jurjus, G., Kwon, K. and Ramirez, L. F. (1997). Outcome of clozapine therapy for elDerly patients with refractory primary psychosis. International Journal of Geriatric Psychiatry, 12, 553-558
18. Stroup, T. S., Gerhard, T., Crystal, S., Huang, C. and Olfson, M. (2014). Geographic and clinical variation in clozapine use in the United States. Psychiatric Services, 65, 186-192
19. Tiihonen, J. et al. (2009). 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet, 374, 620-627
20. Wenthur, C. J. and Lindsley, C. W. (2013). Classics in chemical neuroscience: clozapine. ACS Chemical Neuroscience, 4, 1018-1025